Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prednisolone acetate |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphate |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone tertiary butylacetate |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone adverse reaction |
Causative agent (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical prednisolone adverse reaction |
Causative agent (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone drops adverse reaction |
Causative agent (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rectal prednisolone preparations adverse reaction |
Causative agent (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone measurement (procedure) |
Has measured component |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone measurement (procedure) |
Component |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone tebutate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to prednisolone |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical prednisolone allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone drops allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rectal prednisolone preparations allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone [for preparations see rectal prednisolone] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rectal prednisolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 20mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 20mg/100mL long tube retention enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 20mg/100mL standard tube retention enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 2.5 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 5mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sod phos [musc-sk] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sod phos [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 20mg rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing prednisolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing prednisolone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone (as prednisolone sodium phosphate) 3 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphat 5mg/5mL liquid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphat 6.7mg/5 mL solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphat 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone ophthalmic preparation |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.001% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.003% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.01% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.01% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.03% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.03% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.3% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphate 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphat 20mg/mL injection solution 10mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate 50mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphat 20mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate 50mg/mL injection suspension 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum prednisolone level (procedure) |
Component |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone 20mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 3 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cinchocaine and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone hexanoate 1.3mg / Cinchocaine 1mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing neomycin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone hexanoate (substance) |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
prednisolone métasulfobenzoate |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to prednisolone |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Topical prednisolone allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rectal prednisolone preparations allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone drops allergy |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to prednisolone |
Causative agent (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to ophthalmic prednisolone |
Causative agent (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone caproate (substance) |
Is a |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gentamicin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone caproate (substance) |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone hexanoate (substance) |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphate |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone tertiary butylacetate |
Is modification of (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
prednisolone métasulfobenzoate |
Is modification of (attribute) |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.01% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.03% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 0.3% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone 2.5 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Prednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |